Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 3.38%1.27B | 1.04%1.28B | -2.53%5.06B | 3.70%1.31B | -3.58%1.25B | -7.15%1.23B | -2.84%1.26B | 15.90%5.19B | 7.08%1.26B | 11.15%1.3B |
Cost of revenue | 1.52%1.01B | -3.28%1B | -3.02%4.04B | -2.17%1.03B | -10.11%984.74M | -7.12%993.3M | 8.79%1.04B | 21.93%4.17B | 16.06%1.05B | 20.00%1.1B |
Gross profit | 11.11%266.54M | 21.00%271.36M | -0.55%1.02B | 32.23%285.13M | 31.86%266.48M | -7.27%239.88M | -34.99%224.26M | -3.58%1.02B | -22.17%215.64M | -20.59%202.1M |
Operating expense | -13.22%219.99M | 1.16%213.38M | 4.58%891.59M | 1.24%213.42M | -12.32%213.75M | 10.38%253.49M | 25.31%210.93M | 25.51%852.56M | 25.09%210.82M | 43.55%243.78M |
Staff costs | ---- | ---- | 7.92%351.06M | ---- | ---- | ---- | ---- | 29.70%325.28M | ---- | ---- |
Depreciation and amortization | ---- | ---- | 14.02%102.08M | ---- | ---- | ---- | ---- | 29.74%89.53M | ---- | ---- |
-Depreciation | ---- | ---- | 14.02%102.08M | ---- | ---- | ---- | ---- | 29.74%89.53M | ---- | ---- |
Rent and land expenses | ---- | ---- | -28.50%67.41M | ---- | ---- | ---- | ---- | 77.05%94.28M | ---- | ---- |
Other operating expenses | ---- | ---- | 8.03%371.04M | ---- | ---- | ---- | ---- | 12.16%343.47M | ---- | ---- |
Operating profit | 442.04%46.55M | 335.03%57.98M | -26.46%124.16M | 1,387.35%71.71M | 226.53%52.73M | -146.86%-13.61M | -92.46%13.33M | -55.58%168.84M | -95.56%4.82M | -149.22%-41.68M |
Net non-operating interest income (expenses) | -7,850.00%-775K | -13,020.00%-646K | -691.02%-987K | -6,700.00%-594K | -40,900.00%-408K | 125.64%10K | -97.45%5K | 695.24%167K | 28.57%9K | -80.00%1K |
Non-operating interest income | 0.00%10K | 20.00%6K | -87.84%31K | 22.22%11K | -16.67%5K | 42.86%10K | -97.85%5K | 1,059.09%255K | 28.57%9K | 20.00%6K |
Non-operating interest expense | --785K | --652K | 1,056.82%1.02M | --605K | 8,160.00%413K | --0 | --0 | 8,700.00%88K | --0 | --5K |
Net investment income | -172.11%-486K | 48.32%-123K | -266.07%-1.2M | 24.02%-990K | -238.30%-650K | -37.24%674K | -149.17%-238K | -36.85%725K | -625.40%-1.3M | 581.16%470K |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | 0 | 0 | -1,701.71%-29.42M | -1,707.90%-29.52M | 2K | 2K | 97K | -1.63M | -1.63M | 0 |
Less:Other special charges | ---- | ---- | 89.41%-102K | ---1K | ---2K | ---2K | ---97K | ---963K | ---- | ---- |
Less:Write off | ---- | ---- | 1,037.29%29.52M | ---- | ---- | ---- | ---- | --2.6M | ---- | ---- |
Other non-operating income (expenses) | 0.00%600K | -55.19%600K | 83.43%4.33M | 133.33%770K | 63.64%1.62M | -25.00%600K | 457.92%1.34M | -35.83%2.36M | -68.12%330K | 159.16%990K |
Income before tax | 472.38%45.89M | 297.80%57.81M | -43.17%96.87M | 1,761.61%41.37M | 232.52%53.3M | -139.91%-12.32M | -91.82%14.53M | -55.72%170.45M | -97.98%2.22M | -147.24%-40.22M |
Income tax | 173.00%14.22M | 86.85%25.32M | -14.98%62.85M | 132.96%25.04M | 272.05%19.06M | -65.08%5.21M | -77.17%13.55M | -47.84%73.93M | -77.66%10.75M | -145.64%-11.08M |
Net income | 280.70%31.67M | 3,211.82%32.49M | -64.76%34.01M | 291.38%16.32M | 217.49%34.24M | -209.78%-17.53M | -99.17%981K | -60.31%96.52M | -113.82%-8.53M | -147.89%-29.14M |
Net income continuous operations | 280.68%31.67M | 3,208.45%32.49M | -64.76%34.01M | 291.39%16.32M | 217.49%34.24M | -209.80%-17.53M | -99.17%982K | -60.31%96.52M | -113.82%-8.53M | -147.89%-29.14M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | 280.70%31.67M | 3,211.82%32.49M | -64.76%34.01M | 291.38%16.32M | 217.49%34.24M | -209.78%-17.53M | -99.17%981K | -60.31%96.52M | -113.82%-8.53M | -147.89%-29.14M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 280.70%31.67M | 3,211.82%32.49M | -64.76%34.01M | 291.38%16.32M | 217.49%34.24M | -209.78%-17.53M | -99.17%981K | -60.31%96.52M | -113.82%-8.53M | -147.89%-29.14M |
Gross dividend payment | ||||||||||
Basic earnings per share | 280.77%8.46 | 3,238.46%8.68 | -64.94%9.09 | 290.39%4.36 | 218.83%9.15 | -201.96%-4.68 | -99.17%0.26 | -60.13%25.93 | -114.07%-2.29 | -147.74%-7.7 |
Diluted earnings per share | 271.27%8.03 | 3,200.00%8.25 | -64.08%8.62 | 280.79%4.14 | 218.83%9.15 | -211.36%-4.6884 | -99.14%0.25 | -59.13%24 | -115.28%-2.29 | -152.20%-7.7 |
Dividend per share | ||||||||||
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |